Alembic Pharmaceuticals reports 19% fall in Q2 consolidated net profit

14 Nov 2022 Evaluate

Alembic Pharmaceuticals has reported results for second quarter ended September 30, 2022.

The company has reported a rise of 2.31% in its net profit at Rs 146.44 crore for the quarter under review as compared to Rs 143.13 crore for the same quarter in the previous year. Total income of the company increased by 10.94% at Rs 1354.88 crore for Q2FY23 as compared Rs 1221.32 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported fall of 18.68% in its net profit at Rs 133.35 crore for the quarter under review as compared to Rs 163.99 crore for the same quarter in the previous year. However, total income of the company increased by 12.35% at Rs 1475.34 crore for Q2FY23 as compared Rs 1313.19 crore for the corresponding quarter previous year.

Alembic Pharma Share Price

1044.60 -10.40 (-0.99%)
23-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1814.50
Dr. Reddys Lab 1340.80
Cipla 1476.45
Lupin 2160.20
Zydus Lifesciences 972.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.